Literature DB >> 1891034

Importance of the lay press in the transmission of medical knowledge to the scientific community.

D P Phillips1, E J Kanter, B Bednarczyk, P L Tastad.   

Abstract

BACKGROUND: Efficient, undistorted communication of the results of medical research is important to physicians, the scientific community, and the public. Information that first appears in the scientific literature is frequently retransmitted in the popular press. Does popular coverage of medical research in turn amplify the effects of that research on the scientific community?
METHODS: To test the hypothesis that researchers are more likely to cite papers that have been publicized in the popular press, we compared the number of references in the Science Citation Index to articles in the New England Journal of Medicine that were covered by The New York Times with the number of references to similar articles that were not covered by the Times. We also performed the comparison during a three-month period when the Times was on strike but continued to prepare an "edition of record" that was not distributed; doing so enabled us to address the possibility that coverage in the Times was simply a marker of the most important articles, which would therefore be cited more frequently, even without coverage in the popular press.
RESULTS: Articles in the Journal that were covered by the Times received a disproportionate number of scientific citations in each of the 10 years after the Journal articles appeared. The effect was strongest in the first year after publication, when Journal articles publicized by the Times received 72.8 percent more scientific citations than control articles. This effect was not present for articles published during the strike; articles covered by the Times during this period were no more likely to be cited than those not covered.
CONCLUSIONS: Coverage of medical research in the popular press amplifies the transmission of medical information from the scientific literature to the research community.

Mesh:

Year:  1991        PMID: 1891034     DOI: 10.1056/NEJM199110173251620

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  78 in total

1.  Why were the benefits of tPA exaggerated?

Authors:  Griffin Trotter
Journal:  West J Med       Date:  2002-05

2.  Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs.

Authors:  Alan Cassels; Merrilee A Hughes; Carol Cole; Barbara Mintzes; Joel Lexchin; James P McCormack
Journal:  CMAJ       Date:  2003-04-29       Impact factor: 8.262

3.  Stop press.

Authors: 
Journal:  Nat Chem       Date:  2010-10       Impact factor: 24.427

4.  Print media coverage of research on passive smoking.

Authors:  G E Kennedy; L A Bero
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

5.  Scientific drug information in newspapers: sensationalism and low quality. The example of therapeutic use of cannabinoids.

Authors:  Eva Montané; Marta Duran; Dolors Capellà; Albert Figueras
Journal:  Eur J Clin Pharmacol       Date:  2005-06-28       Impact factor: 2.953

6.  Ageing research in the media. How the demands of newspaper and magazine publishing influence what people read about aging.

Authors:  Laura Helmuth
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

7.  Evaluating the accuracy of health news publications in a drug literature evaluation course.

Authors:  Susannah E Motl; Erin M Timpe; Samantha F Eichner
Journal:  Am J Pharm Educ       Date:  2006-08-15       Impact factor: 2.047

8.  Life and times of the impact factor: retrospective analysis of trends for seven medical journals (1994-2005) and their Editors' views.

Authors:  Mabel Chew; Elmer V Villanueva; Martin B Van Der Weyden
Journal:  J R Soc Med       Date:  2007-03       Impact factor: 5.344

9.  Press-released papers are more downloaded and cited.

Authors:  Simon Chapman; Thien Nga Nguyen; Caroline White
Journal:  Tob Control       Date:  2007-02       Impact factor: 7.552

10.  Colon cancer patient information seeking and the adoption of targeted therapy for on-label and off-label indications.

Authors:  Stacy W Gray; Katrina Armstrong; Angela Demichele; J Sanford Schwartz; Robert C Hornik
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.